Clinical Trial: A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07628127) titled 'A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight' on May 29.

Brief Summary: The primary objective is to evaluate the safety and tolerability of VRB-103 tablets administered as monotherapy or VRB-103 tablets administered in combination with oral ecnoglutide tablets (VRB-101 tablets) in a single-dose regimen or in a multiple dose regimen.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Obesity Overweight

Intervention: DRUG: VRB-103

VRB-103 tablets will be administered orally.

OTHER: Placebo

Placebo tablets will be administered orally....